MultIceNTER peptide vaccine

peptide vaccine · German Cancer Research Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MultIceNTER peptide vaccine, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas [Phase 1]